GridAI Technologies (GRDX) Net Shares Issued and Repurchased (2017 - 2025)
GridAI Technologies' (GRDX) quarterly Net Shares Issued and Repurchased came in at $357.0 in Q4 2025, down 99.47% on a YoY basis from $66884.0 in Q4 2024, and down 92.86% quarter-over-quarter from $5000.0 in Q1 2025.
Analysis
GridAI Technologies (GRDX) Net Shares Issued and Repurchased (2017 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has reported Net Shares Issued and Repurchased for 9 consecutive years, with $357.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Net Shares Issued and Repurchased fell 99.47% year-over-year to $357.0; the trailing twelve-month figure through Dec 2025 stood at $357.0 (down 99.47% YoY), and the FY2025 full-year result was $357.0, down 99.47% from the prior year.
- Net Shares Issued and Repurchased declined to $357.0 in Q4 2025 per GRDX's latest filing, from $5000.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $200652.0 in Q1 2024 and bottomed at $153.0 in Q4 2022.
- Historically, Net Shares Issued and Repurchased has averaged $36997.4 across 5 years, with a median of $5000.0 in 2023.
- The sharpest annual moves came in 2021 and 2024: Net Shares Issued and Repurchased plunged 99.97% in 2021, then soared 12862.02% in 2024.
- Over 5 years, Net Shares Issued and Repurchased stood at $825.0 in 2021, then plunged by 81.45% to $153.0 in 2022, then soared by 237.25% to $516.0 in 2023, then jumped by 12862.02% to $66884.0 in 2024, then sank by 99.47% to $357.0 in 2025.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $357.0, $5000.0, and $66884.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 357.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 66,884.00 |
| Mar 31, 2024 | 200,652.00 |
| Dec 31, 2023 | 516.00 |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | 153.00 |
| Mar 31, 2022 | 3,219.00 |
| Dec 31, 2021 | 825.00 |
| Jun 30, 2021 | 90,000.00 |
| Mar 31, 2021 | 34,365.00 |
| Dec 31, 2020 | 2.88 Mn |
| Jun 30, 2020 | 4,000.00 |
| Mar 31, 2020 | 335,006.00 |
| Dec 31, 2019 | 1.19 Mn |
| Dec 31, 2018 | 539,000.00 |
| Dec 31, 2017 | 545,000.00 |
| Mar 31, 2017 | 55,000.00 |